Search

Your search keyword '"Kankainen, Matti"' showing total 462 results

Search Constraints

Start Over You searched for: Author "Kankainen, Matti" Remove constraint Author: "Kankainen, Matti"
462 results on '"Kankainen, Matti"'

Search Results

1. Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia

2. Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses

3. Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

7. Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia

15. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers

17. P-182 Natural killer cells are active against myeloma cells with loss of tumor suppressor genes

18. P1228: GENOME-WIDE CRISPR-CAS9 SCREENING IDENTIFIES THERAPEUTIC TARGETS FOR MATURE T-CELL MALIGNANCIES

19. ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level

20. Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells

22. Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease

26. Abstract 667: Single-cell functional genomics of natural killer cell evasion by tumor cells

27. Supplementary Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

28. Supplementary Tables from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

29. Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

30. Supplementary Figures from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

32. STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation

35. PI3Kβ inhibition enhances ALK ‐inhibitor sensitivity inALK‐rearranged lung cancer

36. Single-Cell Functional Genomics of Natural Killer Cell Interaction with Blood Cancers

37. Somatic Mutations in T Cells in Patients with Hematological Diseases

38. A Comprehensive, Multiomics Analysis of Natural Killer-Cell Malignancies

39. 1006 Single-cell functional genomics of natural killer cell evasion in blood cancers

40. T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

42. Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

44. Single-cell functional genomics of natural killer cell evasion in blood cancers

47. PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK‐rearranged lung cancer.

49. Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation

50. Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

Catalog

Books, media, physical & digital resources